Overcoming Fragmented Pharma Data for Competitive Intelligence - Claude

Pharmaceutical companies face significant pain points in competitive intelligence (CI), especially around tracking clinical trials, monitoring regulatory changes, and planning pipeline strategy. Current CI workflows are often cumbersome and risky, leading to wasted effort and potential strategic bli PASTED Compare A vs B on scale of 1-10: Pharma CI: The High-Level Challenge Fragmented Data Sources Pharmaceutical competitive intelligence teams often grapple with fragmented data silos. Critical information is scattered across Excel sheets, internal databases, regulatory registries, press releases, and other formats that don’t talk to each other. In fact, 72% of organizations cite fragmented data and siloed teams as their top challenge in managing intelligence . This siloed setup leads to inefficiency – analysts waste hours manually consolidating data – and it creates risk as important insights can slip through the cracks. Data silos drive inefficiencies, cause duplicate work, and limit

saved by

• Eddie Sun